GAD Ab
Pinpoint the autoimmune cause of diabetes and neurological symptoms.
What’s tested
Pick a time
Glutamic acid decarboxylase (GAD) antibodies are autoantibodies directed against the enzyme responsible for producing GABA, a key inhibitory neurotransmitter. This test measures the level of GAD antibodies in a simple blood sample using a validated immunoassay, helping to distinguish autoimmune-driven conditions from other causes.
It is most commonly requested when there is clinical suspicion of type 1 diabetes, latent autoimmune diabetes in adults (LADA), or an autoimmune neurological disorder such as stiff person syndrome, cerebellar ataxia, or limbic encephalitis. It is also used to monitor disease activity in known autoimmune diabetes and to support diagnostic workup in patients presenting with unexplained neurological or metabolic symptoms.
Biomarkers included
Autoimmune Neurology and Endocrinology
- Glutamic acid decarboxylase antibody (GAD Ab)
Why it matters
GAD antibody testing provides critical insight into whether an autoimmune process is driving a patient's diabetes or neurological symptoms. Early identification can guide appropriate treatment, prevent misdiagnosis, and help predict disease progression, enabling more targeted and timely clinical management.
No special fasting required. Drink plenty of water prior to your appointment for a smooth blood draw.
- Identification: Photo ID (Passport or Driving Licence) is only required if you need your report for official, employment, visa/travel, premarital, or Identity-Verified Certificate (IVS) purposes (not required for personal health & wellness testing).
This test provides an official, quality-assured laboratory report with reference ranges. These results are for clinical information and do not replace your GP or consultant. Always discuss abnormal results with your GP or specialist in the context of your medical history.
Related tests in Diabetes
View all →WhatsApp →